Letter from the Director

Neal Hermanowicz,MD — Movement DIsorders Program

UCI has a longstanding commitment to people with Huntington's disease (HD) and their families, both in providing care to patients and in research toward a cure.  We have on our campus a great deal of experience on both fronts.  In the clinic we provide care with knowledge and experience in this uncommon diagnosis.  Moreover, we are able to offer our patients the opportunity to participate in research that enables us to better understand Huntington's disease and also clinical trials  of treatments under study to alter the disease course.

UCI is a participating site in an international study known at ENROLL HD.  This study is a being conducted by investigators around the world to learn more about the disease and also to establish an global network to share ideas and investigate treatments.  UCI also is a site for clinical trials conducted through the Huntington Study Group (HSG), a mostly North American consortium of investigators working together to study new treatments.  Through the HSG we are engaged presently in two trials, both of which are examining methods of potentially slowing the disease progression.